Image

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

Evaluating Amlitelimab for Moderate-to-Severe Atopic Dermatitis Safety and Efficacy.

Recruiting
12 years and older
All
Phase 3

This study is looking at a new treatment called *amlitelimab* for people 12 years and older with moderate-to-severe atopic dermatitis (AD), a skin condition that causes itchy, inflamed skin. The study will compare the drug to a placebo, which is a treatment with no active medicine, to see how well it works and how safe it is. It's a blind study, meaning neither the participants nor the doctors know who gets the real medicine or placebo.

Participants can expect to be involved for up to 44 weeks if they choose not to join a further study, or up to 28 weeks if they do. This includes a screening period and several follow-up visits, totaling up to 10 visits.

  • The study lasts up to 44 weeks with 10 visits.
  • Participants must have had AD for at least a year and weigh over 25 kg.
  • There are specific health conditions that can exclude participation.

This study might be a good fit if other treatments have not worked or are not suitable. Participants need to be willing to attend all visits and follow the study rules.

Study details
    Dermatitis Atopic

NCT06181435

Sanofi

9 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.